ClinicalTrials.gg
Drug

Ropivacaine clinical trials

Also written Naropin, Ropivicaine and TLC590.

studies test it
614
open now
75
in phase 3
86
first study started
2001

How each study uses Ropivacaine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ropivacaine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Sept 1996 · NAROPIN · NDA 020533 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ropivacaine
314
Ropivacaine injection
40
Ropivacaine 0.2% Injectable Solution
18
Ropivacaine 0.5% Injectable Solution
17
Ropivacaine 0.2%
14

Brand

Naropin
108

Development codes

TLC590
5
PRF-110
1

Other names

Ropivicaine
8

In one entry with another drug

Given together, or one or the other

Ropivacaine + Dexmedetomidine
5
Ropivacaine and Dexamethasone
3
Ropivacaine + dexamethasone
3
Ropivacaine and Dexmedetomidine
3
Ropivacaine+Dexamethasone
2
nerve block with 0.5% ropivacaine
2
ropivacaine with dexmedetomidine
2
Ropivacaine plus dexmedetomidine
2

Studies by the year they started

612 studies that test it; most in 2015 (51); 1 more planned to start later

Studies that test Ropivacaine, by start year
YearStudies
20011
20032
20041
20052
20065
200714
200822
200917
201018
201117
201229
201328
201445
201551
201648
201737
201830
201945
202036
202129
202224
202333
202432
202530
202616

By phase

A phase 1/2 study counts in both.

Early Phase 1
13
Phase 1
19
Phase 2
57
Phase 3
86
Phase 4
257
No phase
208

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 597

Poznan University of Medical Sciences (21) · Zealand University Hospital (14) · Nordsjaellands Hospital (6) · Mayo Clinic (6) · San Gerardo Hospital (6) · Hvidovre University Hospital (6) · Asklepieion Voulas General Hospital (5) · Seoul National University Hospital (5)

Often tested with

Tested in the same studies.

Bupivacaine (38) · Epinephrine (29) · Dexmedetomidine (26) · Dexamethasone (17) · Lidocaine (17) · Fentanyl (16) · Ketorolac (16) · Morphine (12)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 5 phase 3 studies under way

Ropivacaine is the comparator. A study of two new drugs counts under both.

  • 3Liposomal Bupivacaine · Feng Gao, Wake Forest University Health Sciences · next primary completion Oct 2027
  • 3Bupivacaine · Feng Gao, Wake Forest University Health Sciences · next primary completion Oct 2027
Reaching primary completion within a year · 30

Studies that test Ropivacaine.

Studies

Open first, then newest update. How each study uses Ropivacaine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 614

See all 614 studies that test Ropivacaine →

Given beside what is tested · 120 — Ropivacaine is usual care or a partner of the new treatment

Showing 20 of 120.

As the comparator · 63 — what is tested is compared with Ropivacaine

Showing 20 of 63.

Codes

What other systems call Ropivacaine · ClinicalTrials.gg INT006667

  • MeSH (NLM) D000077212RopivacaineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7IO5LYA57NROPIVACAINEConfirmed FDA, NLM, Wikidata
  • RxNorm 35780Confirmed FDA, Wikidata
  • Wikidata Q279504(S)-ropivacaineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61932RopivacaineOne source FDA
  • DrugBank DB00296One source Wikidata

Also registered as ropivacaine hydrochloride (UNII V910P86109 · RxNorm 1298851).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.